Arif, Sefina <br/><br/>
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells.  [electronic resource] 

 -  Diabetologia  06 2020 
 - 1186-1198 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-020-05130-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD4-Positive T-Lymphocytes--metabolism<br/>Cell Line<br/>Cryopreservation<br/>Diabetes Mellitus, Type 1--immunology<br/>Humans<br/>Immunotherapy--methods<br/>Randomized Controlled Trials as Topic<br/>Receptors, Antigen, T-Cell--metabolism<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology